Knowledge base
Publications 2025:
Consensus statement on mesotherapy for clinical and regulatory practice
_____________
Blood biomarkers of inflammation and brain-derived neurotrophic factor can not be used to assess the effectiveness of collagen mesotherapy in chronic cervical myofascial pain syndrome. A pilot single-blind randomized study
Publications 2025:
A Retrospective Analysis of the Effectiveness and Safety of Collagen Mesotherapy in the Course of Chronic Cervical Myofascial Pain Syndrome
_____________
The role of mesotherapy in chronic back pain syndrome: what do we know?
_____________
Spinal collagen mesotherapy in patients with chronic thoracic back pain:
a retrospective analysis of effectiveness and safety in a 3-month follow-up
_____________
International Consensus Guidelines on the Safe and Evidence-Based Practice
of Mesotherapy: A Multidisciplinary Statement
Publications 2024:
Efficacy and Safety of Spinal Collagen Mesotherapy in Patients with Chronic Low Back Pain in a Three-Month Follow-Up—Retrospective Study
_____________
The Role of Rehabilitation after Spinal Mesotherapy in a Three-Stage Treatment Concept
Publications 2023:
Mesotherapy as a New Emergency Medicine Tool for Spinal Injuries
Publications 2021:
The use of mesotherapy in spinal pain syndrome
Publications 2018:
The importance of mesotherapy in treating musculoskeletal pain